BioCentury | Dec 10, 2015
Distillery Therapeutics
Therapeutics: Homeobox A9 (HOXA9); poly(ADP-ribose) polymerase (PARP); myeloid-lymphoid or mixed-lineage leukemia (MLL; HRX)
...I to Phase III testing to treat hematologic malignancies and multiple solid tumor types. TARGET/MARKER/PATHWAY: Homeobox A9 (HOXA9)...